J Korean Med Assoc.  2013 Sep;56(9):755-761. 10.5124/jkma.2013.56.9.755.

Medical environment and drug abuse among physicians: current state and problems in Korea

• Park SS

• KMID: 2015671
• DOI: http://doi.org/10.5124/jkma.2013.56.9.755

Abstract

Currently, the number of reports of propofol abuse in the general population and among physicians has increased, arousing public concerns about drug abuse. It is especially easy for physicians to access various drugs, and thus they are prone to abuse drugs. However, the data on physicians' drug abuse in the Republic of Korea remains insufficient. In this article, we estimated the state of current drug abuse among the Korean general population and the assumed rate and tendency toward drug abuse among physicians based on published data. The current prevalence of drug abuse in Korea is around 4%, and the physicians' rate may not differ from that of the general population. According to the data on drug-related crime in Korea, 1% of such crimes are associated with medical personnel. Opioids are used more frequently by medical personnel than the general population (6.2% vs. 18.1%). Even though drug abuse is commonly related to personality problems and comorbid psychological disorders, social and environmental factors are also important. Burnout problems due to the stresses of a heavy workload in the hospital with sleep deprivation, rapidly expanding medical knowledge, and increasing government regulations are additional important causes of drug abuse among physicians. However, few studies on drug abuse and physician burnout have been performed in Korea. Although the rate of physicians' drug abuse is similar to that in the general population, the prevalence is disturbing because physicians are responsible for the health and well-being of the general population. Therefore, detailed research about physicians' drug abuse and burnout is needed, and proper solutions to prevent and treat drug abuse should be established.

Keyword

Professional burnout; Substance-related disorders; Physicians

MeSH Terms

Analgesics, Opioid
Burnout, Professional
Crime
Government Regulation
Korea
Prevalence
Propofol
Republic of Korea
Sleep Deprivation
Street Drugs
Substance-Related Disorders
Analgesics, Opioid
Propofol
Street Drugs

Figure

• 

  Figure 1 Trends in the prevalence of drug-related criminals in South Korea [57].

Reference

1. Korean Association Against Drug Abuse. World research: analysis of public perception on severity of drug abuse 2012 [Internet]. Seoul: Korean Association Against Drug Abuse;2012. cited 2013 Aug 12. Available from: http://drugfree.or.kr/drug_bbs/board.php?board=datatext&config=&command=body&no=144.

2. McGovern MP, Angres DH, Leon S. Characteristics of physicians presenting for assessment at a behavioral health center. J Addict Dis. 2000; 19:59–73.

3. Lee S, Lee MS, Kim YA, Ahn W, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med. 2010; 34:101–107.

4. Lee MS, Ahn W. Designation of a new drug as a controlled substance. J Korean Med Assoc. 2011; 54:189–196.

5. Supreme Prosecutors' Office. Statistic analysis of drug related criminals at 2012 in Korea [Internet]. Seoul: Korean Association Against Drug Abuse;cited 2013 Aug 12. Available from: http://www.drugfree.or.kr/drug_bbs/board.php?board=drug5&command=body&no=543.

6. Supreme Prosecutors' Office. Statistic analysis of drug related criminal at 2013 in Korea [Internet]. Seoul: Korean Association Against Drug Abuse;2013. cited 2013 Aug 12. Available from: http://www.drugfree.or.kr/drug_bbs/board.php?board=drug5&config=&command=body&no=551.

7. Kang EY, Lee SS. A study on drug abuse and attitudes toward drug. Seoul: Korean Institute of Criminology;2004. p. 224.

8. US Department of Health and Human Services. Results from the 2011 national survey on drug use and health: summary of national findings [Internet]. Rockville: Substance Abuse and Mental Health Services Administration;2012. cited 2013 Aug 12. Available from: http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.htm.

9. United Nations Office on Drug and Crime. World drug report 2013 [Internet]. Vienna: United Nations Office on Drug and Crime;2013. cited 2013 Aug 12. Available from: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf.

10. Berge KH, Seppala MD, Schipper AM. Chemical dependency and the physician. Mayo Clin Proc. 2009; 84:625–631.

11. Baldisseri MR. Impaired healthcare professional. Crit Care Med. 2007; 35:2 Suppl. S106–S116.

12. Hughes PH, Brandenburg N, Baldwin DC Jr, Storr CL, Williams KM, Anthony JC, Sheehan DV. Prevalence of substance use among US physicians. JAMA. 1992; 267:2333–2339.

13. Hughes PH, Storr CL, Brandenburg NA, Baldwin DC Jr, Anthony JC, Sheehan DV. Physician substance use by medical specialty. J Addict Dis. 1999; 18:23–37.

14. McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ. 2008; 337:a2038.

15. Association of American Medical Colleges. 2008 Physician specialty data: center for workforce studies [Internet]. Washington, DC: Association of American Medical Colleges;2008. cited 2013 Aug 12. Available from: https://www.aamc.org/download/47352/data.

16. Paris RT, Canavan DI. Physician substance abuse impairment: anesthesiologists vs. other specialties. J Addict Dis. 1999; 18:1–7.

17. Hamza H, Bryson EO. Exposure of anesthesia providers in recovery from substance abuse to potential triggering agents. J Clin Anesth. 2011; 23:552–557.

18. Talbott GD, Wright C. Chemical dependency in health care professionals. Occup Med. 1987; 2:581–591.

19. Gold MS, Melker RJ, Dennis DM, Morey TE, Bajpai LK, Pomm R, Frost-Pineda K. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. J Addict Dis. 2006; 25:15–21.

20. Wischmeyer PE, Johnson BR, Wilson JE, Dingmann C, Bachman HM, Roller E, Tran ZV, Henthorn TK. A survey of propofol abuse in academic anesthesia programs. Anesth Analg. 2007; 105:1066–1071.

21. Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology. 2000; 93:922–930.

22. Lew EA. Mortality experience among anesthesiologists, 1954-1976. Anesthesiology. 1979; 51:195–199.

23. Kang EY, Lee SS. An empirical study on drug abuse and demand reduction strategies. Seoul: Korean Institute of Criminology;2005. p. 289.

24. Jaffe JH. Substance-related disorders. In : Sadock BJ, Sadock VA, editors. Kaplan & Sadock's comprehensive textbook of psychiatry. 7th ed. Philadelphia: Lippincott Williams & Wilkins;2000. p. 924–1095.

25. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004; 61:807–816.

26. Kim DJ, Jho GH, Che SH, Choi MM, Oh SY, Lee KM, Joo NH. A fact-finding survey on the people addicted to drug in year 2009. Seoul: Catholic University;2010. p. 263.

27. Baldwin DC Jr, Hughes PH, Conard SE, Storr CL, Sheehan DV. Substance use among senior medical students: a survey of 23 medical schools. JAMA. 1991; 265:2074–2078.

28. Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, West CP, Sloan J, Oreskovich MR. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012; 172:1377–1385.

29. Whippen DA, Canellos GP. Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Clin Oncol. 1991; 9:1916–1920.

30. Oreskovich MR, Kaups KL, Balch CM, Hanks JB, Satele D, Sloan J, Meredith C, Buhl A, Dyrbye LN, Shanafelt TD. Prevalence of alcohol use disorders among American surgeons. Arch Surg. 2012; 147:168–174.